CohBar Inc.

0.1771+0.0012+0.68%Vol 260.88K1Y Perf -86.26%
Jun 27th, 2022 16:00 DELAYED
BID0.1766 ASK0.1880
Open0.1845 Previous Close0.1759
Pre-Market- After-Market0.19
 - -  0.01 4.97%
Target Price
2.88 
Analyst Rating
Strong Buy 1.33
Potential %
1.53K 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/60 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/71 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/91 
Income Ranking
 —    -
Price Range Ratio 52W %
0.34 
Earnings Rating
Neutral
Market Cap7.65M 
Earnings Date
9th Aug 2022
Alpha-0.03 Standard Deviation0.29
Beta2.52 

Today's Price Range

0.17600.1890

52W Range

0.17002.27

5 Year PE Ratio Range

-10.20-6.90

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-3.14%
1 Month
-0.28%
3 Months
-46.53%
6 Months
-54.90%
1 Year
-86.26%
3 Years
-90.44%
5 Years
-89.27%
10 Years
-

TickerPriceChg.Chg.%
CWBR0.17710.00120.68
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.03-0.04-33.33
Q04 2021--0.04-
Q03 2021-0.09-0.0544.44
Q02 2021-0.07-0.08-14.29
Q01 2021-0.06-0.07-16.67
Q04 2020-0.06-0.08-33.33
Q03 2020-0.05-0.0420.00
Q02 2020-0.06-0.09-50.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.0484.62Positive
9/2022 QR-0.0588.64Positive
12/2022 FY-0.13--
12/2023 FY-0.21--
Next Report Date9th Aug 2022
Estimated EPS Next Report-0.04
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume260.88K
Shares Outstanding43.17K
Shares Float86.94M
Trades Count836
Dollar Volume47.29K
Avg. Volume371.42K
Avg. Weekly Volume298.54K
Avg. Monthly Volume358.39K
Avg. Quarterly Volume457.34K

CohBar Inc. (NASDAQ: CWBR) stock closed at 0.1759 per share at the end of the most recent trading day (a -8.43% change compared to the prior day closing price) with a volume of 455.90K shares and market capitalization of 7.65M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 13 people. CohBar Inc. CEO is Steven B. Engle.

The one-year performance of CohBar Inc. stock is -86.26%, while year-to-date (YTD) performance is -49.73%. CWBR stock has a five-year performance of -89.27%. Its 52-week range is between 0.17 and 2.27, which gives CWBR stock a 52-week price range ratio of 0.34%

CohBar Inc. currently has a PE ratio of -0.90, a price-to-book (PB) ratio of 0.69, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -68.64%, a ROC of -75.50% and a ROE of -75.77%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from CohBar Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.04 for the next earnings report. CohBar Inc.’s next earnings report date is 09th Aug 2022.

The consensus rating of Wall Street analysts for CohBar Inc. is Strong Buy (1.33), with a target price of $2.88, which is +1 526.20% compared to the current price. The earnings rating for CohBar Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CohBar Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CohBar Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 19.77, ATR14 : 0.03, CCI20 : -106.20, Chaikin Money Flow : -0.12, MACD : -0.01, Money Flow Index : 33.61, ROC : -7.32, RSI : 39.31, STOCH (14,3) : 7.38, STOCH RSI : 0.00, UO : 29.11, Williams %R : -92.63), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CohBar Inc. in the last 12-months were: David L. Greenwood (Buy at a value of $0), Joseph J. Sarret (Buy at a value of $22 400), Kenneth C. Cundy (Option Excercise at a value of $7 300), Kenneth C. Cundy (Sold 10 000 shares of value $20 100 ), Misha Petkevich (Buy at a value of $96 175), Nir Barzilai (Buy at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
3 (75.00 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.25

CohBar Inc.

CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States.

CEO: Steven B. Engle

Telephone: +1 650 446-7888

Address: 1455 Adams Drive, Menlo Park 94025, CA, US

Number of employees: 13

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

54%46%

Bearish Bullish

54%46%

News

Stocktwits